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ABSTRACT 
 
Evaluation of the Dairy/Yeast Prebiotic, GroBiotic®-A, in the Diet of 
Juvenile Nile Tilapia, Oreochromis niloticus. (December 2011) 
Anjelica Maria Peredo, B.S., Texas A&M University 
Co-Chairs of Advisory Committee: Dr. Delbert M. Gatlin III
                                                  Dr. Alejandro Buentello 
 
Two different feeding trials were conducted to evaluate the effects of dietary 
supplementation with the dairy/yeast prebiotic GroBiotic®-A (GBA) to Nile tilapia diets.  
A nutritionally complete basal diet was supplemented with GBA at either 1 or 2% of dry 
weight, and all three diets were fed to triplicate groups of juvenile fish in two 
consecutive trials.  Trial 1 continued for 8 weeks, while Trial 2 was conducted for 5 
weeks to more specifically assess immunological responses, intestinal characteristics and 
disease resistance of tilapia.  At the conclusion of Trial 1, there were no differences in 
weight gain (WG) or feed efficiency (FE) among fish fed the three diets.  However, fish 
fed the diet with GBA at 2% had significantly increased survival and noticeably elevated 
levels of plasma lysozyme compared to fish fed the basal diet or the diet with GBA at 
1%.  Similarly, at the conclusion of Trial 2, WG and FE were unaffected by GBA 
supplementation; however, fish fed the diet with GBA at 2% also exhibited elevated 
plasma lysozyme as well as significantly (P < 0.05) increased levels of extracellular 
superoxide anion production (EX-SOAP) by macrophages.  Dendrogram analysis of 
denaturing gradient gel electrophoresis (DGGE) images detected a significantly different 
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microbial community within the intestine of fish fed the diet with GBA at 2% compared 
to fish fed the basal diet and diet with GBA at 1%.  None of the experimental diets 
resulted in significant improvements to survival after exposure to Streptococcus iniae 
due to within treatment variability.  However, fish fed the diet with GBA at 2% did tend 
to experience reduced mortality (12.5%) as compared to fish fed the basal diet (35%).  
Thus, supplementation of GBA at 2% of diet did alter the gut microbiota of tilapia and 
enhanced immunological responses and disease resistance to S. iniae. 
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1 
INTRODUCTION 
Over the past decade, as the world’s population has continued to increase 
exponentially, aquaculture has played an integral role in providing a safe and sustainable 
seafood alternative to commercial capture fisheries.  According to the United Nations’ 
Food and Agriculture Organization (FAO), capture fisheries’ production levels have 
remained relatively static over the past several decades; whereas, aquacultural 
production has continued to increase to meet the world’s growing seafood demand, and 
now contributes over half of the total (FAO 2010).  Tilapia, one of the most commonly 
farmed species of fish, is among the top contributors to the overall production in finfish 
aquaculture.  As of 2008, world aquaculture production of Nile tilapia, alone, was at 
2,334,432 tonnes (FAO 2005-2010). 
As the demand for seafood from aquaculture continues to grow, production 
systems will need to become increasingly efficient.  However, several factors currently 
constrain aquaculture production with the single most costly problem being the loss of 
fish due to disease, which is facilitated by high stocking densities, poor water quality 
conditions, and improper nutrition.  In the past, the heavy and indiscriminate use of 
antibiotics to combat various diseases in aquaculture led to increased concerns regarding 
resistant strains of bacterial fish pathogens as well as drug-resistance in microorganisms 
present in the natural environment.  Also worrisome was the escalating presence of 
antibiotic residues in fish tissues (Alderman & Hastings 1998; Cañada-Cañada et al. 
2009) 
____________ 
This thesis follows the style of the journal Aquaculture Nutrition. 
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In response to these concerns, significant progress has been made over the past 
several years regarding the dietary inclusion of various immunomodulators.  A variety of 
feed additives, including non-nutritive immunostimulatory compounds such as microbial 
cells or cellular fractions from brewer’s yeast, β-glucans, peptidoglycans, chitin and 
oligonucleotides, as well as probiotics or live microbial dietary supplements, also have 
received more extensive evaluation with fish in recent years (Nakagawa et al. 2007; 
Gatlin & Li 2008).  One specific group of non-nutritive compounds that has gained 
considerable notoriety is that of prebiotics.  These substances were first described as 
non-digestible food ingredients that beneficially affect the host by selectively stimulating 
the growth and/or activity of one or a limited number of beneficial bacteria in the 
gastrointestinal tract (GIT, Gibson & Roberfroid 1995).  Due to the increasing amount of 
prebiotic research conducted in recent years, the definition has been upgraded to 
distinguish a prebiotic as a selectively fermented ingredient that fosters specific changes, 
both in the composition and/or activity of the GIT microbiota, which confer benefits 
upon host well-being and health (Gibson et al. 2004). 
Commonly used prebiotics that have been evaluated in various aquatic species 
include inulin, mannanoligosaccharides (MOS), fructooligosaccharides (FOS), short-
chain fructooligosaccharides (scFOS), GroBiotic®-A (GBA), and to a lesser extent, 
galactooligosaccharides (GOS), xylooligo-saccharides (XOS), 
arabinoxylooligosaccharides (AXOS), and isomaltooligosaccharides (IMO).  Table 1 
summarizes several studies in which prebiotics have been evaluated with aquacultured 
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organisms.  RingØ et al. (2010) and Yousefian & Amiri (2009) also have recently 
provided comprehensive reviews of prebiotic use in aquaculture.  
 
 
 
Table 1  Summary of prebiotic use in aquaculture 
Prebiotic Dose (g kg
-1
); 
duration of 
trial 
Species Initial  
Wt. (g) 
Response
a
 Reference 
Inulin 150; 4 weeks Arctic charr 
(Salvelinus 
alpines L.) 
218 Intestinal cell damage Wang & Wang 
(1997) 
 75; 3 weeks Atlantic salmon  
(Salmo salar L.) 
218 → Intestinal cell 
damage; ↑ Intestinal 
growth and relative 
mass of the 
gastrointestinal tract 
Refstie et al. 
(2006) 
 5 and 10; 1 
week 
Gilthead 
seabream (Sparus 
aurata L.) 
175 Significant inhibition 
of phagocytosis and 
respiratory burst in 
leucocytes 
Cerezuela et al. 
(2008) 
 20; 1 month Turbot  larvae 
(Psetta maxima)  
n/a ↑ Growth rate; Effects 
on gut microbiota 
(Bacillus and Vibrio) 
Mahious et al. 
(2006b) 
MOS 10; 4 months Atlantic salmon  200 ↓ Oxygen 
consumption; ↓ Protein 
and ↑ energy 
concentration in the 
whole body 
Grisdale-Helland 
et al. (2008) 
 2; 4 weeks Channel catfish 
(Ictalurus 
punctatus) 
16.0 → Growth 
performance, 
hematology, or 
immune function 
Welker et al. 
(2007) 
 20 and 40; 67 
days 
European sea 
bass 
(Dicentrarchus 
labrax) 
33.7 ↑ Growth; → Feed 
conversion; ↓Lipid 
vacuolization; ↓ 
Presence of Vibrio 
alginolyticus on head 
kidney 
Torrecillas et al. 
(2007) 
 2; 90 days Rainbow trout 
(Oncorhynchus 
mykiss) 
30.0 ↑ Growth and survival; 
↑ Antibody titer and 
lysozyme activity  
Staykov et al. 
(2007) 
 2; 8 weeks Rainbow trout n/a ↑ Absorptive surface in 
the posterior gut 
region; ↑ Microvilli 
density and length 
Dimitroglou et 
al. (2008) 
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Table 1 continued 
Prebiotic Dose (g kg-
1
); 
duration of 
trial 
Species Initial  
Wt. (g) 
Response
a
 Reference 
MOS, 
contin. 
0 and 4; 12 
weeks 
Rainbow trout 13.2 ↑ Growth; ↑ 
Hemolytic and 
phagocytic activity; ↑ 
Mucus weight; 
↑Survival against 
Vibrio anguillarum 
Rodrigues-
Estrada et al. 
(2008) 
 0, 2 and 6; 58 
days 
Hybrid tilapia 
(Oreochromis 
niloticus × O. 
aureus)  
8.1 → Growth rate; ↑ 
Survival; ↑ Non-
specific immunity 
He et al. (2003) 
 10; 4 weeks Red drum 
(Sciaenops 
ocellatus) 
10.9 ↑ Feed efficiency; ↑ 
survival following 
parasitic challenge; ↑ 
Non-specific 
immunity 
Buentello, et al. 
(2010) 
FOS 10; 4 months Atlantic salmon  200 → Feed intake, 
growth or digestibility 
Grisdale-
Helland et al. 
(2008) 
 10; 4 weeks Red drum 
 
10.9 ↑ Non-specific 
immunity 
Buentello, et al. 
(2010) 
 0, 2 and 6; 58 
days 
Hybrid tilapia  57.0 → Growth rate; ↑ 
Survival; ↑Non-
specific immunity 
He et al. (2003) 
 20; 1 month Turbot larvae  n/a ↑ Growth rate; Effects 
on gut microbiota 
(Bacillus and Vibrio) 
Mahious et al. 
(2006b) 
 2.5; 100 days Soft-shell turtle 
(Triortyx 
sinensis) 
n/a ↑ Growth rate; ↑ SOD 
activity; ↓Lysozyme 
activity 
Ji et al. (2004) 
scFOS 0.8 and 1.2; 8 
weeks 
Hybrid tilapia  5.6 ↑ Growth rate, feed 
intake, feed 
conversion; → 
Survival  
Hui-Yuan et al. 
(2007) 
GBA 10 and 20; 4 
(Trial 1) and 7 
(Trial 2) 
weeks 
Hybrid striped 
bass (Morone 
chyrsops × M. 
saxatilis) 
91.4 
(Trial 1) 
and 19.7 
(Trial 2) 
↑ Feed efficiency; ↑ 
Respiratory bursts; ↑ 
Resistance against 
Streptococcus iniae 
Li & Gatlin 
(2004) 
 10; 6 weeks Red drum 2.4 → WG or FE; → 
Intestinal microbiota 
Burr et al. 
(2009) 
 10; 4 weeks Red drum 10.9 ↑ Feed efficiency; 
enhanced WG; ↑ 
survival following 
parasitic challenge; ↑ 
Non-specific 
immunity 
Buentello et al. 
(2010) 
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Table 1 continued 
Prebiotic Dose        
(g kg-1); 
duration 
of trial 
Species Initial  
Wt. (g) 
Response
a
 Reference 
GBA, 
contin. 
20; 16 
weeks 
Hybrid striped 
bass 
64.5 ↑ Growth 
performance, ↑ 
Resistance against 
Mycobacterium 
marinum 
Li & Gatlin 
(2005) 
 20; 16 
weeks 
Golden shiner 
(Notemigonus 
crysoleucas) 
1.06 ↑ Resistance against 
Flavobacterium 
columnare 
Sink et al. 
(2007) 
 20; 10 
weeks 
Golden shiner  0.46 → Survival; 
↑Resistance against 
Flavobacterium 
columnare 
Sink & 
Lochmann 
(2008) 
 10; 3 
weeks 
Red drum  500 ↑ Protein, lipid and 
organic ADC values 
Burr et al. 
(2008) 
 10; 4 
weeks 
Red drum  10.9 ↑ FE; ↑ enhanced 
weight gain; ↑ 
Survival following 
Amyloodinium 
ocellatum; ↑ non-
specific immune 
responses 
Burr et al. 
(2009) 
 10 and 20; 
8 weeks 
Hybrid striped 
bass 
34.4 → WG or FE Burr et al. 
(2010) 
 20 ; 9 Rainbow trout 14.3 → WG or FE; 
→antibody levels 
Sealey et al. 
2007 
XOS 0, 0.15, 2.1 
and 3.2; 45 
days 
Crucian carp 
(Carassius 
auratus gibelio) 
17.0 ↑ Growth; → Survival; 
↑ Enzymatic activity 
 Xu et al. (2009) 
aArrows indicate an increase (↑), decrease (↓), or no change (→) in the response 
 
 
 
Previous studies with various fish species in our laboratory revealed that 
prebiotics have the capacity to afford a range of beneficial effects including improved 
performance indices (Li & Gatlin 2005; Buentello et al. 2010; Zhou et al.2010), 
increased immunological responses (Buentello et al. 2010; Zhou et al.2010), changes to 
the intestinal morphology (Zhou et al.2010), and, most notably, enhanced survival 
following disease challenge against various bacterial (Li & Gatlin 2005) and parasitic 
  
 
6 
(Buentello et al. 2010) pathogens.  In addition to the previously stated prebiotic benefits, 
these compounds may also favor the proliferation of beneficial bacteria (in lieu of 
potentially pathogenic microorganisms) within the intestine.  Such effects have been 
demonstrated in various animals, including poultry (Spring et al. 2000; Patterson & 
Burkholder 2003), swine (Smiricky-Tjardes et al. 2003; Konstantinov et al. 2004), and 
various fish species (Burr et al. 2008; 2010).   
Additionally, GBA supplementation has been shown to improve the nutrient 
value of plant feedstuffs, enhance non-specific immune responses and increase disease 
resistance in fish (Li & Gatlin, 2004; 2005; Sealey et al. 2007; Burr et al. 2008; 
Buentello et al. 2010).  Therefore, the objective of the current study was to evaluate the 
responses of Nile tilapia (Oreochromis niloticus) to graded levels of the dairy/yeast 
prebiotic GBA, with respect to performance indices, selected non-specific immune 
responses, intestinal microbiota and histology, as well as disease resistance following a 
controlled bacterial challenge. 
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MATERIALS AND METHODS 
 An initial 8-week feeding trial (Trial 1) and a 5-week follow-up trial (Trial 2) 
were conducted at the Texas A&M University Aquacultural Research and Teaching 
Facility (ARTF).  Prior to the start of both feeding trials, all fish were fed a conditioning 
diet twice daily (a.m. and p.m.) for 2 weeks.  During this conditioning phase the fish 
became acclimated to the culture system and other environmental conditions.   
 Diet Formulation   
A nutritionally complete basal diet was formulated to contain approximately 35% 
crude protein on a dry-matter basis.  Experimental diets were formulated by 
supplementing the basal diet with GBA at 1% or 2% of dry weight in place of cellulose 
(Table 2).  The resulting three diets were evaluated in both trials. 
 All diets were prepared at the ARTF as previously described by Li and Gatlin 
(2004).  Dry ingredients were mixed in a V-mixer followed by the blending of oil and 
water with the dry ingredients in a food mixer.  Then 3-mm pellets were prepared using 
a commercial blender with a meat grinding attachment.  Each diet was crumbled to a 
size small enough to be consumed by the fish.   
Culture System and Feeding Trials 
 Both feeding trials were conducted in a closed, recirculating system consisting of 
110-L glass aquaria.  Salinity was maintained at 2 ppt by mixing a synthetic sea salt 
blend and sodium chloride with well water.  Water quality was maintained within 
acceptable levels for tilapia using mechanical and biological filtration, and supplemental 
aeration was provided to each aquarium via an airstone to achieve oxygen levels near air 
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saturation.  Water temperature was maintained at 26 + 1°C by conditioning ambient air, 
and a 12-h light:12-h dark photoperiod was achieved with fluorescent lights controlled 
by timers. 
 
 
 
Table 2  Composition of experimental diets (% dry weight) 
 
Diet 
Ingredient (%) Basal 1% GBA 2% GBA 
Menhaden fish meal1 10.0 10.0 10.0 
Soybean meal, dehulled2 45.0 45.0 45.0 
Dextrin3 25.0 25.0 25.0 
Menhaden oil1 2.0 2.0 2.0 
Vitamin premix4 3.0 3.0 3.0 
Mineral premix4 4.0 4.0 4.0 
Carboxymethyl cellulose3 2.0 2.0 2.0 
CaPO4, dibasic5 1.0 1.0 1.0 
Corn oil3 1.4 1.4 1.4 
Casein3 4.6 4.6 4.6 
Celufil3 2.0 1.0 0.0 
GroBiotic-A6 0.0 1.0 2.0 
Proximate composition (%)7 
   Dry matter 88.3 86.2 87.8 
Crude protein 38.2 38.7 39.3 
Crude lipid 5.9 5.7 6.2 
Ash 8.7 8.6 8.9 
1 OmegaProtein Corporation, Houston, TX, USA 
2 Rangen Inc., Angleton, TX, USA 
3 US Biochemical Corporation, Cleveland, OH, USA 
4 Same as Moon and Gatlin (1991) 
5 Fisher Scientific, Pittsburgh, PA, USA 
6 International Ingredient Corp., St. Louis, MO, USA 
7 Means of two replicate analysis per sample expressed on a dry-matter basis 
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Trial 1.  For Trial 1, fish were obtained from Til-Tech Aquafarm in Robert, LA.  This 
company produces all-male progeny of genetically male tilapia (GMT) using the “Y-Y 
male technology” developed by Fishgen Ltd. at the University of Swansea in Wales.   A 
total of 225 fish with an initial weight of 4 to 5 g/fish were randomly divided into nine 
tanks.  Twenty-five individuals were then graded by size and stocked into each aquarium 
such that their collective weight differed by ≤ 5%.   
Each diet was randomly assigned to three replicate tanks, with fish in each 
aquarium receiving their respective diet initially at a rate of 6% of body weight (BW) per 
day divided into two feedings.  The feeding rate was gradually reduced equally among 
all treatments over the course of the trial to 4% BW to maintain a rate close to apparent 
satiation without overfeeding.  Fish in each aquarium were collectively weighed once 
every week to monitor weight gain and adjust the feed ration accordingly.  This feeding 
trial continued for an 8-week period following the methodologies established by similar 
studies conducted with tilapia (He et al. 2003; Hui-Yuan et al. 2007). 
 
Trial 2.  Trial 2 was conducted to more specifically evaluate the immunological 
responses and disease resistance of tilapia fed the same experimental diets.  Mixed sex 
fish for Trial 2 were obtained from Simaron Freshwater Fish, Inc., Hempstead, TX.  A 
total of 270 (6 to 7 g/fish) disease-free juvenile fish were randomly divided into nine 
aquaria.  Similar group weights were achieved by sorting the fish so as to ensure limited 
variation among aquaria (≤ 5%).  Each experimental diet was provided to fish in three 
randomly assigned aquaria and weekly weight gain was monitored as previously 
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described.  After 5 weeks of feeding, fish were subjected to a controlled challenge with 
Streptococcus iniae.  This time interval was chosen based on previous studies conducted 
with GBA (Li & Gatlin 2004) and Nile tilapia (Samrongpan et al. 2008) which included 
a disease challenge component.   
 
Bacterial challenge.   Prior to the actual challenge, a previously obtained isolate of 
Streptococcus iniae was propagated in brain-heart infusion (BHI, Becton, Dickinson and 
Company, Sparks, MD) and passed through two fish to assure virulence.  A preliminary 
LD50 was conducted in order to ascertain the proper concentration of colony forming 
units (CFU) needed to achieve 50% survival 1 week after disease exposure.  Following 
the 5-week feeding period in Trial 2, 40 fish from each dietary treatment were randomly 
selected and subjected to the pathogenic challenge.  These fish received an 
intraperitoneal injection (~0.6 mL/10 g BW) of BHI broth inoculated with virulent 
bacteria.  After injection, fish were transferred to an isolated recirculating system and 
stocked at a rate of 20 fish/tank, with two replicate aquaria per dietary treatment.  Based 
on the LD50 assay, the concentration of S. iniae was targeted to be approximately 5.37 
x107 CFU/mL and this concentration was confirmed via replicate plate counts.  Fish 
mortality was then monitored for 21 days following the injection. 
 
Immune responses.  At the end of Trial 1 three fish from each tank were humanely 
euthanized using tricaine methane sulfonate (MS-222, 200 mg/mL; Western Chemical 
Inc., Ferndale, WA, USA) to collect various biological samples.  Blood was collected 
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from the caudal vasculature using heparinized 1-mL syringes in order to assay selected 
non-specific immune responses which would indicate the state of immune system 
function at the time of sampling.  A portion of the whole-blood was used to determine 
neutrophil oxidative radical production with nitro blue tetrazolium (NBT) as described 
by Siwicki et al. (1994).  Plasma was then separated by centrifuging the remaining blood 
at 3,000 × g for 10 min and then kept at -80°C until lysozyme activity was determined 
according to the assay of Jorgensen et al. (1993).  The same procedures were undertaken 
following the conclusion of Trial 2, but only two fish per aquarium were sampled.   
At the conclusion of Trial 2, in addition to the two immunological assays 
described above, superoxide anion production from kidney macrophages also was 
determined as described by Secombes (1990) with modifications in order to further 
assess the level of immune system function.  Head and trunk kidneys from all remaining 
fish in each treatment (7 to 10 fish per aquaria) were dissected and placed into separate 
15-mL vials containing 5-10 mL of Leibovitz (L-15) media with L-glutamine (Sigma-
Aldrich Co., St. Louis, Mo).  Macrophage isolation and estimation (Buentello & Gatlin 
1999) as well as the detection of extracellular and intracellular superoxide anion 
production (Sealey & Gatlin 2002) were then assessed. 
 
Denaturing gradient gel electrophoresis.  Following the conclusion of Trial 1, digesta 
from the intestines of three fish per tank was pooled into a sterile, DNase-free 
microcentrifuge tube and immediately frozen in liquid nitrogen.  The digesta was then 
used to determine possible differences in the microbial communities within the GIT 
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according to the procedures described by (Hume et al. 2003).  Genomic DNA was 
isolated from ~0.2 g of thawed digesta with QIAGEN’s QIAamp® DNA Mini Kit 
(Valencia, CA, USA), and 250 ng of template DNA per sample were combined   
Polymerase Chain Reaction (PCR) was conducted by combining bacteria-specific PCR 
primers (Burr et al. 2010) targeting the conserved regions flanking the variable V3 
region of 16S rDNA, with Jump Start Red-Taq Ready Mix (Sigma Chemical Company, 
St. Louis, MO, USA), bovine serum albumin, to help stabilize the reaction, and 250 ng 
of template DNA, per sample collected, and run according to the following thermocyler 
(PTC-200 Peltier Thermal Cycler; MJ Research, MJ Research, Inc., Waltham, MA) 
program: 1) denaturation at 94.9 C for 2 min; 2) subsequent denaturation at 94.0 C for 
1 min; 3) annealing at 67.0 C for 45 sec; -0.5 C per cycle (touchdown to minimize 
spurious by-products (Don et al. 1991; Wawer & Muyzer 1995)); 4) extension at 72.0 C 
for 2 min; 5) repeat steps 2 to 4 for 17 cycles; 6) denaturation at 94 C for 1 min; 7) 
annealing at  58.0 C for 45 sec; 8) repeat steps 6 to 7 for 12 cycles; 9) extension at 72.0 
C for 7 min; 10) 4.0 C holding temperature.  Denaturing gradient gel electrophoresis 
(DGGE) was conducted using the following modification: 1 µL of PCR product from 
each of three tanks per treatment was pooled accordingly and added to 3 µL of 2X 
loading buffer, then loaded onto a corresponding well of an 8% polyacrylamide gel 
[(vol/vol) acrylamide-bisacrylamide ratio of 37:5:1 (Bio-Rad, Richmond, CA, USA) 
with a 35% to 60% urea-formamide gradient (100% was 7 M urea and 40% deionized 
formamide) using a DCode System (Bio-Rad, Hercules, CA, USA) with 0.5x TAE 
buffer (20 mM Tris (pH 7.4), 10 mM sodium acetate, 0.5 M EDTA) at 59 C for 17 h at 
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60 V.  Gels were stained with SYBR Green I (Sigma).  The same techniques were 
applied at the conclusion of Trial 2 pooling the digesta of two fish per aquarium. 
The analysis of band pattern relatedness was determined with Molecular 
Analysis Fingerprinting software (v 1.6; Bio-Rad, Hercules, CA).  This analysis is based 
on the Dice similarity coefficient (SC) and the un-weighted pair group method using 
arithmetic averages for clustering.  Comparisons between sample band patterns was 
expressed as a percentage SC (SC > 95% means two populations are identical; SC ≤ 95 
and  ≥ 80 means two populations are similar; SC < 80 means two populations are 
significantly different). 
 
Histology.  After the conclusion of Trial 1, a single intestine from one fish per tank was 
injected with Davidson's fixative solution (acetic acid:95% ethanol:formaldehyde:H2O at 
a 1:3:2:3 ratio) and fixed for 24 h, after which it was transferred to a 70% ethanol 
solution for long-term storage.  Segments (~1 cm length) of proximal, middle and distal 
intestine were sliced, embedded in paraffin and transverse sections were processed to 4-
μm slides and stained with hematoxylin and eosin.  The slides were examined under a 
light microscope (Olympus, Bx60, Center Valley, PA, USA) equipped with a digital 
camera (Donpisha, XC-003P) and VGA 460 Osteomeasure software (Osteometrics, 
Decatur, GA) for image acquisition.  Electronic images were further analyzed using 
Image J software (National Institutes of Health, Bethesda, MD, USA) for assessing 
dimensions of intestinal folds, enterocytes and microvilli in different enteric sections (10 
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measurements per section per fish).  The same technique was applied to fish from Trial 
2, using the intestines of two fish from each aquarium. 
 
Statistical analysis.  Analysis of variance (ANOVA) was used to determine significant 
(P < 0.05) dietary effects with regard to the performance indices, immunological assays 
and histological measurements.  All statistical analyses were performed using JMP 9 
(SAS Institute Inc., Cary, NC, USA). 
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RESULTS 
Trial 1 
Performance indices.  Weight gain and feed efficiency values of juvenile Nile tilapia 
were similar across all three dietary treatments (Table 3); however, at the end of the 8-
week feeding trial, fish fed the diet containing 2% GBA showed significantly (P < 0.05) 
increased survival. 
 
Immunological responses.  Selected non-specific immune responses are shown in Table 
3.  Neutrophil oxidative radical production (NBT) was not significantly (P > 0.05) 
affected by prebiotic supplementation.  Lysozyme activity in plasma tended to increase 
with dietary GBA supplementation, although statistical significance was not achieved.   
 
 
 
Table 3  Performance indices and non-specific immune responses of Nile tilapia fed 
experimental diets for 8 weeks (Trial 1)* 
Diet 
WG
§ 
(%) 
FE 
(g gain/g fed) 
Survival 
(% ) 
NBT
‡ 
(U mg
-1
 protein) 
Lysozyme
‡
 
(U ml
-1
) 
Basal 670 0.66 90.7ab 5.08 79.0 
1% GBA 704 0.65 86.9b 4.94 90.0 
2% GBA 669 0.65 98.7a 5.06 111.7 
P> F
†
 0.95 0.98 0.04 0.81 0.26 
PSE 87.6 0.03 2.56 0.16 12.81 
* Values represent the means of three replicate aquaria unless otherwise noted. Values in the same    
column with different superscript letters are significantly different (P < 0.05) 
§ Weight gain (WG) as a percent of initial weight 
† Significance probability associated with the F statistic 
‡Means of nine fish per dietary treatment 
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Intestinal microbial analysis.  Dendrogram analysis (Figure 1) showed that the 
microbial communities found within fish fed the experimental diets were very similar 
(SC = 94.7%), being almost identical to each other.  The microbial composition of 
digesta from fish fed the basal diet was very similar to that obtained from fish fed both 
of the GBA-supplemented diets (SC = 91.0%), indicating that GBA supplementation did 
not significantly affect the microbial composition within the GIT of juvenile Nile tilapia 
at the time of sampling.   
 
 
 
 
Figure 1  Dendrogram analysis of the microbial community in the intestine of tilapia fed experimental 
diets in Trial 1 
 
Histology.  An overview of the histological measurements from Trial 1 is shown in 
Table 4.  Fish fed the basal diet had significantly increased fold height in the proximal 
intestine.  Fish fed diets supplemented with 1% GBA experienced significantly increased 
total enterocyte height in the middle section of the intestine and significantly increased 
microvilli height in the distal intestine when compared to fish fed the basal and 2% GBA 
diets.  Fish fed 2% GBA diets experienced significantly increased fold height in the 
distal section of the intestine when compared to the other diets.   
 
 
 
94.7 
91.0 
  
 
17 
Table 4  Histomorphometric measurements (m) of the proximal, middle and distal sections of 
intestine (Trial 1)* 
Diets Basal   1% GBA   2% GBA   ANOVA   
Proximal 
 
P> F PSE 
Fold height 334.1a 
 
295.6b 
 
307.2b 
 
0.02 9.55 
Total enterocyte height 40.3 
 
42.9 
 
44.2 
 
0.13 1.35 
Microvilli height 1.9 
 
2.0 
 
2.2 
 
0.06 0.09 
         Middle 
        Fold height 191.7 
 
168.0 
 
159.0 
 
0.12 11.56 
Total enterocyte height 32.5b 
 
37.9a 
 
34.5b 
 
0.01 1.18 
Microvilli height 2.1 
 
2.4 
 
2.1 
 
0.08 0.10 
         Distal 
        
Fold height 112.4b 
 
119.7b 
 
177.7a 
 
0.00 11.04 
Total enterocyte height 42.9 
 
43.6 
 
41.7 
 
0.45 1.07 
Microvilli height 1.7b   2.1a   1.9ab   0.01 0.07 
* Data represent means of 10 independent measurements from one fish per aquarium (three per dietary     
treatment).  Values in the same row with different superscript letters are significantly different (P < 
0.05) 
 
 
 
Trial 2 
Immunological responses.  At the end of the 5-week period in Trial 2, values for 
neutrophil oxidative radical production were relatively similar for fish fed the different 
diets (Table 5).  Lysozyme production tended to increase with the amount of GBA in the 
diet, with fish fed the 2% GBA diet having the highest numerical value, although 
statistical significance was not reached (Table 5).  Extracellular super oxide anion 
production (EX-SOAP) of fish fed the diet containing 2% GBA was significantly higher 
than that of fish fed the basal diet.  Intracellular superoxide anion (IN-SOAP) was 
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numerically highest in fish fed the diet with GBA at 2%, but no statistical significance 
was attained.   
 
Intestinal microbial analysis.  The dendrogram analysis (Figure 2) of samples obtained 
from fish in Trial 2 showed two distinct groups of microbial communities brought about 
by the different experimental diets.  The microbiota found in the digesta of fish fed the 
basal and 1% GBA diets were remarkably similar (SC = 92.5%).  However, fish fed the 
2% GBA diet showed a very different microbial community based on the DGGE 
analysis (SC = 71.9%).   
 
Histology.  Histological measurements from Trial 2 are summarized in Table 6.  Fish fed 
the basal diet experienced significantly increased microvilli height in the proximal 
intestine, as well as significantly increased fold height in the middle section of the 
intestine.  Fish fed the 1% GBA diet experienced significantly increased total enterocyte 
height in the middle section of the intestine as well as significantly increased fold height 
in the distal intestine.  Fish fed the 2% GBA diet only experienced statistically 
significant increases in fold height in the proximal intestine.  
 
Bacterial challenge.  Fish fed the diet supplemented with 2% GBA experienced 
noticeably higher survival during the bacterial challenge when compared to fish fed the 
basal and 1% GBA diets (Figure 3).  However, due to within treatment variability, a P-
value of only 0.33 was achieved.   
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Table 5  Selected non-specific immune responses of tilapia fed experimental diets for 5 weeks 
(Trial 2) 
Diet  
NBT
*
 
(U mg
-1
 protein) 
Lysozyme
*
 
(U ml
-1
) 
EX-SOAP
‼
 
(nmol O2
-
) 
IN-SOAP
†
 
(OD)
 
Basal 7.16 61.7 0.29b 0.18 
1% GBA 6.67 76.7 0.63ab 0.19 
2% GBA
 6.83 81.7 0.75a 0.24 
P> F 0.87 0.81 0.04 .20 
PSE 0.67 22.49 0.09 .02 
* Means of two fish from each of the three replicate aquaria per dietary treatment.  Values in the  
   same column with different superscript letters are significantly different (P < 0.05) 
‼ Extracellular superoxide anion production 
†
 Intracellular superoxide anion production, optical density at 620 nm  
 
 
 
 
 
 
 
 
 
Figure 2  Dendrogram analysis of the microbial community in the intestine of tilapia fed experimental 
diets in Trial 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
92.5 
71.9 
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Table 6  Histomorphometric measurements (m) of the proximal, middle and distal sections of 
intestine (Trial 2)*  
Diet Basal   1% GBA   2% GBA   ANOVA   
Proximal 
 
P> F PSE 
Fold height 321.2a 
 
315.2a 
 
272.9b 
 
0.00 8.30 
Total enterocyte height 38.1 
 
37.6 
 
36.5 
 
0.29 0.71 
Microvilli height 1.9a 
 
1.8ab 
 
1.7b 
 
0.03 0.05 
         Middle 
        
Fold height 227.4a 
 
182.3b 
 
180.0b 
 
0.00 8.07 
Total enterocyte height 29.6a 
 
33.2b 
 
32.2a 
 
0.00 0.71 
Microvilli height 2.0 
 
2.0 
 
2.0 
 
0.81 0.07 
         Distal 
        
Fold height 150.3b 
 
174.4a 
 
148.0b 
 
0.01 6.51 
Total enterocyte height 36.3a 
 
32.7b 
 
35.6a 
 
0.01 0.93 
Microvilli height 2.4   2.3   2.3   0.69 0.08 
* Data represent means of 10 independent measurements from 2 fish per aquarium (six per dietary 
treatment).  Values in the same row with different superscript letters are significantly different 
(P < 0.05) 
 
 
 
Figure 3  Survival of fish challenged with Streptococcus iniae 
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DISCUSSION 
In the current study, GBA supplementation into a 35% crude protein diet was 
unable to significantly affect WG or FE of Nile tilapia.  These results are in stark 
contrast to a recently published study also supplementing GBA to Nile tilapia where a 
significant increase in both WG and FE were reported for fish fed a diet containing 29% 
crude protein and GBA (Zheng et al. 2011).  The higher protein concentration in the 
former trial may have negated any beneficial effects on WG and FE, since Zheng et al. 
(2010) failed to see any difference in the WG or FE of fish fed diets containing GBA 
when compared to another control diet used in that study with a higher crude protein 
level (33%).   
Nevertheless, such intraspecific, as well as interspecific discrepancies are fairly 
common in prebiotic studies (RingØ et al. 2010) and may be largely attributed to initial 
differences in the composition of intestinal microbiota, although this has not been tested 
in most studies.  Certain members of the microbiota are more apt to utilize certain 
prebiotic substrates over others (Cummings et al. 2001; Sanz et al. 2006) and the initial 
presence or absence of these bacteria will affect the overall outcome.  Differences in the 
size or age of fish (Li & Gatlin 2004; 2005) used in prebiotic studies may also have an 
impact due to the degree of establishment, or lack thereof, with respect to a stable 
microbiota (Burr et al. 2009; Nayak 2010).  Differences in dietary ingredients across 
studies may also be responsible for the differences observed.  Despite the variation in 
and between trials, prebiotic supplementation has been proven to increase WG (Mahious 
et al. 2006a; 2006b; Zhou et al. 2007; Rodrigues-Estrada et al. 2008; Xu et al. 2009) and 
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FE (Li & Gatlin 2004; Hui-Yuan et al. 2007; Li et al. 2007; Zhou et al. 2007) in several 
species of aquatic organisms.  In contrast to the reported inconsequential impact GBA 
had on the survival of hybrid striped bass (Li & Gatlin 2004) and red drum (Buentello et 
al. 2010), in the current study, fish fed the diet containing 2% GBA had significantly 
higher trial survival than the other two dietary treatments (Table 3).  Similar increases in 
survival throughout the length of the trial have been demonstrated in hybrid tilapia (He 
et al. 2003), and rainbow trout (Staykov et al. 2007) fed diets supplemented with FOS 
and MOS, respectively.  It is important to point out the majority of research regarding 
GBA has been conducted on carnivorous, rather than herbivorous or omnivorous fish 
(Table 1; RingØ et al. 2010) 
The most notable outcome of prebiotic supplementation, in general, is changes 
brought about to the intestine, both morphologically and microbiologically.  Changes to 
the morphology of the intestine may be attributed to the production of short-chain fatty 
acids through the microbial fermentation of prebiotic substances.  A study in which 
short-chain fatty acids were added to the media resulted in the inhibition of epithelial 
cell proliferation of caecal tissue in vitro (Sakata 1987), while in vivo studies have 
demonstrated stimulated intestinal cell proliferation in rats and pigs (Sakata 1984; Kien 
et al. 2007).  This led to the implication that the proliferative effects of short-chain fatty 
acids are indirect (Sakata 1987).  Proof of short-chain fatty acids production from GBA 
has been demonstrated by Burr et al. (2010) in red drum, but no such data exists for Nile 
tilapia.  The ambiguous histological data (Tables 4 & 6) may point to the fact that short-
chain fatty acid production, or the undefined indirect mechanism, is limited or non-
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existent, particularly in the distal intestine which is the primary site of prebiotic action 
(Gibson & Roberfroid 1995).  However, what is clear is that dietary supplementation of 
GBA at 2% did not result in the expected increase in microvilli height seen in other 
prebiotic studies involving different fish species (Yilmaz et al. 2007; Salze et al. 2008; 
Zhou et al. 2010).  In fact, it seems that GBA supplementation had marginally 
detrimental effects (Tables 4 & 6).  However, further research is warranted in order to 
establish a volatile fatty acid profile and attempt to elucidate the indirect mechanisms 
that may affect intestinal morphology of Nile tilapia fed diets supplemented with GBA.   
Despite the inconclusive morphological data seen in this study as a whole, and 
the lack of change in microbial community seen in the initial trial, inclusion of GBA at 
2% in the follow-up trial was the only dietary treatment able to significantly alter the 
intestinal microbiota (Figure 2).  Although the exact nature of this shift was not 
identified, it may be safe to assume, as a preliminary hypothesis, that it was towards the 
accumulation of more beneficial bacteria, rather than pathogenic, based on the overall 
results of the study.  Similar beneficial shifts have been reported with this prebiotic, 
inulin, MOS, and GOS in hybrid striped bass (Burr 2007) and with GBA in red drum as 
well (Burr et al. 2008).  A possible explanation for the lack of change demonstrated in 
the initial trial may be due to an initially high level of beneficial bacteria already being 
present in the intestine of these fish.  This is plausible, considering the fact that when the 
microbial communities of the control treatments from both trials were run on a single gel 
and then analyzed using DGGE, they shared a similarity coefficient of < 80%, signifying 
that the two different populations of fish used in each trial did not start off with the same 
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microbial community composition.  Differences within species, such as this is not 
unfathomable, considering that the initial colonization and subsequent establishment 
process of the enteric microbiota can be greatly affected by the initial rearing conditions, 
which in the two populations of fish used in this study where geographically different 
(Nayak 1990).   
In the current study, fish fed the diet containing GBA at 2% exhibited 
significantly increased EX-SOAP.  Increases in lysozyme and IN-SOAP were generally 
seen as the percent inclusion of GBA increased, but no statistical significance was 
reached.  The significant increase in EX-SOAP is not surprising, given that GBA 
contains constituents of dairy ingredient components, dried fermentation products, and 
autolyzed brewers’ yeast.  The brewers’ yeast component contains β-glucans and 
nucleotides, which have been shown to induce immunological responses in fish (Li & 
Gatlin 2006; Dalmo & Bogwald 2008).  Previous studies involving prebiotic 
supplementation to fish also have been shown to enhance similar aspects of the non-
specific immune system, such as plasma lysozyme activity, neutrophil oxidative radical 
production, IN-SOAP, and EX-SOAP (Li & Gatlin 2004; 2005; Buentello et al. 2010; 
Zheng et al. 2011).   
What might have the greatest impact, in terms of increasing aquaculture 
production, is how each of the above components may have worked in concert to 
increase the ability of Nile tilapia to ultimately resist disease.  Fish fed the diet 
containing GBA at 2% experienced noticeably higher survival than fish fed either of the 
other two diets in feeding Trial 1and after the controlled disease challenge in Trial 2.  
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Since lysozyme is most effective against gram-positive bacteria and readily increases 
when bacteria is present, the elevated levels seen in this study (Table 5) may have 
allowed the lysozyme to increase to such a level as to partially control S. inaie when 
introduced into the fish (Saurabh & Sahoo 2008).  However, since lysozyme activity was 
not assayed following the conclusion of the challenge, this hypothesis cannot be verified.  
The significant increase associated with the production of EX-SOAP would have likely 
been another aspect of the immune system working to keep the infection under control 
and reduce mortality, especially because S. iniae has been shown to display anti-
phagocytic properties which would render IN-SOAP of macrophages useless  (Agnew & 
Barnes 2007).   
The drastic difference in challenge survival in the current study could indicate 
that GBA inclusion above 1% is required to evoke any noticeable change in survival.  
This theory is supported by the research conducted by Zheng et al. (2011), where GBA 
included at a level over 1% resulted in the highest survival following a disease challenge 
with Aeromonas hydrophila.  Numerous other studies have demonstrated the ability of 
GBA to increase survival following bacterial challenges with golden shiners exposed to 
Flavobacterium columnare (Sink et al. 2007; 2008; 2010), and hybrid striped bass 
exposed to Aeromonas hydrophila and Streptococcus iniae (Li and Gatlin 2004; 2005).  
Supplementation of GBA into the diet of rainbow trout has also proven to be effective in 
increasing survival when challenged with infectious hematopoietic virus (Sealey et al. 
2007).  Further research is warranted in order to continue characterizing the effects of 
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GBA supplementation in the diets of various fish species commonly cultured in 
aquaculture production systems. 
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SUMMARY 
The link between gut health and the overall well-being and disease resistance of 
an animal is now starting to inundate the aquaculture industry as a possible solution to 
increased mortality associated with a decrease in optimal environmental conditions and 
subsequent disease outbreaks.  Through numerous studies, both in vitro and in vivo, 
prebiotics have been shown to trigger a beneficial shift in intestinal microbiota, leading 
to the cascade of advantageous effects previously mentioned.   
The present study highlighted the ability of GBA supplementation to beneficially 
affect several aspects of host physiology when supplemented into the diet of juvenile 
Nile tilapia.  Although GBA supplementation was unable to increase the weight gain or 
feed efficiency in the current study, it resulted in the establishment of a significantly 
different microbial community within the intestine, coupled with the up regulation of 
several immune responses; ultimately resulting in considerably decreased mortality 
following a bacterial challenge with the aquatic pathogen S. iniae.  Other studies 
supplementing GBA have reported similar findings, but further research is required 
regarding the microbial characterization of tilapia intestine and other fish species in 
order to gain a better understanding of the direct and indirect effects garnered by GBA 
supplementation.   
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